Dr Reddy's Laboratories gains despite reporting 29% fall in Q4 consolidated net profit

17 May 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5224.15, up by 28.30 points or 0.54% from its previous closing of Rs. 5195.85 on the BSE.

The scrip opened at Rs. 5286.75 and has touched a high and low of Rs. 5286.75 and Rs. 5143.50 respectively. So far 45452 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3613.45 on 18-May-2020.

Last one week high and low of the scrip stood at Rs. 5422.00 and Rs. 5143.50 respectively. The current market cap of the company is Rs. 86820.05 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.

Dr Reddys Laboratories has reported a fall of 38.05% in its net profit at Rs 311.50 crore for the quarter ended March 31, 2021 as compared to Rs 502.80 crore for the same quarter in the previous year. However, total income of the company increased by 15.21% at Rs 3432.30 crore for Q4FY21 as compared Rs 2979.10 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 28.65% in its net profit and share of profit of associates at Rs 557.30 crore for the quarter ended March 31, 2021 as compared to Rs 781.10 crore for the same quarter in the previous year. However, total income of the company increased by 7.26% at Rs 4850.80 crore for Q4FY21 as compared Rs 4522.50 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a fall of 25.57% in its net profit at Rs 2186.40 crore as compared to Rs 2937.70 crore for the previous year. However, total income of the company increased by 12.36% at Rs 14150.20 crore for year under review as compared to Rs 12593.60 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a fall of 3.67% in its net profit and share of profit of associates at Rs 1951.60 crore as compared to Rs 2026.00 crore for the previous year. However, total income of the company increased by 6.62% at Rs 19338.90 crore for year under review as compared to Rs 18137.60 crore for year ended March 31, 2020.

Dr. Reddys Lab Share Price

1267.15 -7.90 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×